Program Sunday 16 October 2022

Time

Trianti Hall (T)

Banqueting Hall (B)

Skalkotas Hall (S)

08.00 – 09.00

Registration
Welcome coffee, tea and breakfast bites (Muses Foyer)

09.00 – 10.05

T1. Opening session
7th WoCoVA

  • 09.00 – 09.20 (T1.1)
    Opening
    Ton van Boxtel (NL)

  • 09.20 – 10.00 (T1.2)
    Economic perspective on vascular access
    Dafne Kaitelidou (GR)

  • 10.00 – 10.05 
    Commercial break

10.05 – 11.05

T2. What’s new in the world of venous access?
Chairs: Roberto Biffi (IT) and 
Sergio Bertoglio (IT)

  • 10.05 – 10.25 (T2.1)
    A nurse’s point of view
    Evangelos Konstantinou (GR)

  • 10.25 – 10.45 (T2.2)
    A physician’s point of view
    Massimo Lamperti (AE)

  • 10.45 – 11.05 
    Discussion

11.05 – 11.15

Short break (Muses Foyer)

11.15 – 12.00

Industry symposium 1

Industry symposium 2

Industry symposium 3

12.00 – 13.00

Lunch break (Muses Foyer)
Poster presentations

13.00 – 14.05

T3. Cyanoacrylate glue for venous access
Chairs: Jocelyn Hill (CA) and
Matt Ostroff (US)

  • 13.00 – 13.20 (T3.1)
    Glue for peripheral VADs
    Amit Bahl (US)

  • 13.20 – 13.40 (T3.2)
    Glue for central VADs
    Mauro Pittiruti (IT)

  • 13.40 – 14.00
    Discussion

  • 14.00 – 14.05
    Commercial break

B1. The proper choice of the venous access device
Chairs: Christian Dupont (FR) and Evangelos Konstantinou (GR)

  • 13.00 – 13.20 (B1.1)
    The choice between peripheral and central access
    Kathy Kokotis (US)

  • 13.20 – 13.40 (B1.2)
    The VAD-Expert approach
    Fulvio Pinelli (IT)

  • 13.40 – 13.50 (B1.3)
    Indications for venous access in oncology -recommendations of national professional societies and the current state in the Czech Republic
    Viktor Manasek (CZ)

  • 13.50 – 14.00
    Discussion

  • 14.00 – 14.05
    Commercial break

S1. CLABSI in NICU and PICU
Chairs: Roland van Rens (NL) and Christian Breschan (AT)

  • 13.00 – 13.20 (S1.1)
    Prevention of CRBSI: state of the art
    Agnes van den Hoogen (NL)

  • 13.20 – 13.40 (S1.2)
    Skin Antisepsis in neonates and children
    Giancarlo Scoppettuolo (IT)

  • 13.40 – 14.00
    Discussion

  • 14.00 – 14.05
    Commercial break

14.05 – 15.05

T4. Ultrasound for venous access: not only venipuncture
Chairs: Antonio La Greca (IT) and
Tim Spencer (US)

  • 14.05 – 14.25 (T4.1)
    Ultrasound for detection of catheter-related complications
    Daniele G. Biasucci (IT)

  • 14.25 – 14.45 (T4.2)
    Advantages of ultrasound for tip navigation and tip location
    Emanuele Iacobone (IT)

  • 14.45 – 15.05 
    Discussion

B2. Infection prevention in 2022: fighting extraluminal contamination
Chairs: Nancy Moureau (US) and
Marcia Ryder (US)

  • 14.05 – 14.25 (B2.1)
    Infective complications of short peripheral cannulas
    Victor Rosenthal (US)

  • 14.25 – 14.45 (B2.2)
    Prevention of bacterial contamination by the extraluminal route: the state of the art
    Giancarlo Scoppettuolo (IT)

  • 14.45 – 15.05
    Discussion

S2. The choice of VAD in children
Chairs: Amanda Ullman (AU) and
Giovanni Barone (IT)

  • 14.05 – 14.25 (S2.1)
    The choice of VAD in children with oncologic diseases Alessandro Crocoli (IT)

  • 14.25 – 14.45 (S2.2)
    Vascular approaches in infants and children: French pediatric recommendations, tips and tricks
    Eric Desruennes (FR)

  • 14.45 – 14.55 (S2.3)
    Effective use of extended dwell peripheral intravenous catheters in neonatal
    Jessica Marchetti (US)

  • 14.55 – 15.05
    Discussion

15.05 – 15.45

Networking break (Muses Foyer)

15.45 – 17.00

T5. The changing paradigm of femoral access
Chairs: Matt Ostroff (US) and
Andrew Bodemham (GB)

  • 15.45 – 16.05 (T5.1)
    The SIF protocol
    Fabrizio Brescia (IT)

  • 16.05 – 16.25 (T5.2)
    Access to the superficial femoral vein
    Maria Giuseppina Annetta (IT)

  • 16.25 – 16.35 (T5.3)
    Comparison of femorally inserted central catheters with peripherally inserted central catheters by propensity scoring analysis
    Evan Alexandrou (AU)

  • 16.35 – 17.00 
    Discussion

B3. Infection prevention in 2022: fighting intraluminal contamination
Chairs: Giancarlo Scoppettuolo (IT)
and Evan Alexandrou (AU)

  • 15.45 – 16.05 (B3.1)
    Prevention of bacterial contamination by the intraluminal route: the state of the art
    Marcia Ryder (US)

  • 16.05 – 16.25 (B3.2)
    VADs with antibacterial coating: a review of the evidence
    Tim Spencer (US)

  • 16.25 – 16.35 (B3.3)
    Performance evaluation of central venous catheters with two different antimicrobial technologies against Staphylococcus aureus infection
    Nisha Gupta (US)

  • 16.35 – 17.00 
    Discussion

S3. New standards for venous access in neonates
Chairs: Agnes van den Hoogen (NL) and Mauro Pittiruti (IT)

  • 15.45 – 16.05 (S3.1)
    Peripheral and ventral VADs in neonates: new tecniques and new materials
    Giovanni Barone (IT)

  • 16.05 – 16.25 (S3.2)
    Ultrasound access in neonates: the role of the brachio-cephalic vein
    Christian Breschan (AT)

  • 16.25 – 16.35 (S3.3)
    Impacting neonatal patient care: reducing needle sticks, with an extended dwell catheter
    Constance Girgenti (US)

  • 16.35 – 16.45 (S3.4)
    Outcomes of establishing a neonatal peripheral vascular access team
    Roland van Rens (QA)

  • 16.45 – 17.00
    Discussion

17.00 – 18.00

Welcome speech, networking and refreshments (Muses Foyer)